Skip to content
The Longevity Archive
Berobenatide in all countries

Legal status · United States

Is Berobenatide legal in the United States?

InvestigationalMetabolicEvidence: Moderate

No. Berobenatide is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Berobenatide in the United States at a glance

ClassificationInvestigational, not approved
FDA approval statusInvestigational; Phase 3 program planned 2026
Evidence levelModerate (research strength: Moderate)
ReviewedSep 2026

Classification and note come from the Berobenatide profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.

What this means

  • 01

    Berobenatide is being studied in registered clinical trials but has not received FDA marketing approval in the United States.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What Berobenatide is

An ultra-long-acting GLP-1 agonist with a roughly 15-day half-life built for once-monthly injection, the centerpiece of Pfizer's Metsera acquisition and now heading into ten Phase 3 trials.

Berobenatide uses an albumin-binding 'halo-lipidation' design that stretches the half-life of a fully biased GLP-1 receptor agonist to about 360 hours. 3% placebo-adjusted loss at week 28 with no plateau.

Mechanism: Long-acting GLP-1 receptor agonism (appetite suppression, slowed gastric emptying) with an engineered half-life that allows weekly induction followed by monthly dosing.

Regulatory history: Investigational; Phase 3 program planned 2026

How FDA treats this kind of product

Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.

The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Berobenatide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Berobenatide in other countries

Frequently asked questions

Is Berobenatide legal in the United States?

No. Berobenatide is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Can I buy Berobenatide in the United States?

No approved product exists to buy. In the United States Berobenatide is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Berobenatide FDA approved?

No. FDA status: Investigational; Phase 3 program planned 2026. Current US classification: "Investigational, not approved". Evidence level: Moderate.

Related compounds in the United States

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Berobenatide live on its compound profile.

Berobenatide profile

This page is general information about the regulatory status of Berobenatide in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.